Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Oculentis Declares Bankruptcy | OBN
Oculentis B.V. has been declared bankrupt by order of the District Court Gelderland of September 6, 2021. Mr. E.R. Looijen is the bankruptcy trustee, and Mr. M.J.C. van Leeuwen is the delegated judge. Legal Issues Over Faulty Intraocular Lenses Bankruptcy was…
What Is Suprachoroidal Hemorrhage? | OBN
What Is Suprachoroidal Hemorrhage? Suprachoroidal hemorrhage is a sight-destroying pathology. It arises when there is a rupture of long or short ciliary arteries during an intraocular surgery and blood is contained in the space between the choroid and the sclera.…
Corneal Staining: Causes, Symptoms and Management
Corneal staining is a critical concept in the field of eye health, referring to a condition where the cornea, the clear front surface of the eye, becomes stained or discolored. This phenomenon is particularly significant because it often indicates underlying…
RVL Launches Prescription E-Commerce Platform
RVL Pharmaceuticals recently introduced a proprietary prescription e-commerce platform known as ELEVATE. This platform aims to provide a hassle-free and secure subscription service that offers a seamless and efficient solution for purchasing RVL products for both healthcare providers and patients.…
Study Estimates $5.2M Cost of Vision Loss in Australia
In a groundbreaking study published in the Medical Journal of Australia, researchers have quantified the lifetime cost of living with an inherited eye disease in Australia, revealing it to be $5.2 million per person. Shockingly, a significant portion of these…
Dysthyroid Optic Neuropathy and Its Management
Dysthyroid optic neuropathy (DON) is a condition that arises from the complex interplay between thyroid dysfunction and ocular health. Often associated with autoimmune thyroid disorders such as Graves’ disease, DON can lead to significant vision impairment and impact an individual’s…
What Is Capsulorhexis and How It’s Done
What Is Capsulorhexis? Capsulorhexis, derived from the Latin “capsula” (little container) and Greek “rhexis” (rupture), refers to the precise and controlled tear of the anterior lens capsule during cataract surgery. This procedure creates a circular opening through which the cloudy…
All About Phacoemulsification Procedure | OBN
The phacoemulsification procedure has transformed cataract surgery, offering a less invasive and more efficient method for cataract removal. This advanced surgical technique uses ultrasonic vibrations to emulsify the cloudy lens, which is then aspirated out and replaced with an artificial…
GenSight Withdraws Application for Lumevoq in Europe
GenSight Biologics announced that it is withdrawing its application submitted to the European Medicines Agency (EMA) seeking approval for Lumevoq (lenadogene nolparvovec) in patients with Leber hereditary optic neuropathy (LHON). The decision comes after the Committee for Advanced Therapies (CAT)…
Brim Biotech’s Clinical Trial for DED Kicks Off
BRIM Biotechnology has initiated the Phase 3 clinical trial of BRM421 for the treatment of Dry Eye Disease (DED) and enrolled the first patient in the trial. This multicenter, double-blind, randomized, vehicle-controlled trial will enroll over 700 patients with moderate…